U.S., Jan. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07313176) titled 'Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease' on Dec. 17, 2025.

Brief Summary: The primary objective of the study is to assess the effectiveness of LECIGON(R) treatment on the reduction in OFF time (h/day) from baseline at 12 months as measured by Movement Disorder Society-Unified Parkinson's Disease Rating Scale, Part IV (MDS-UPDRS IV).

Study Start Date: Jan., 2026

Study Type: OBSERVATIONAL

Condition: Advanced Parkinson Disease

Intervention: OTHER: No Intervention

This is a non-interventional study.

Recruitment Status: NOT_YET_RECRUITING

Sponsor: B...